Acasti Pharma Reports Third Quarter 2023 Operational Results
https://www.acasti.com/en/investors/news-events/press-releases/detail/246/acasti-pharma-reports-third-quarter-2023-operational-results
WebLAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced financial and operational results for the third quarter ended …
DA: 75 PA: 31 MOZ Rank: 27